SEC Form 4 · accession 0001140361-15-037320
CytomX Therapeutics, Inc. · CTMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Matthew P. Young
Director
Period of report
Oct 7, 2015
Accepted (ET)
Oct 9, 2015 · 4:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001501989
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $12.00 | Oct 7, 2015 | A | 26,985 | A | — | Oct 6, 2025 | Common Stock | 26,985 | 26,985 | D |
Explanation of responses
- F1This option provides for early exercise and is immediately exercisable. This option vests in 36 substantially equal monthly installments starting on the last day of September 2015.
Remarks
Exhibit 24.1 - Power of Attorney (incorporated by reference to the Power of Attorney filed as Exhibit 24.1 to the Form 3 filed by the reporting person on October 7, 2015)